| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |